Close

Anti-MGMT DNA-encoded mAb (DMAb), pVAX1 (DMAb-2230-FY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-MGMT DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • MGMT
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 4255
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-2230-FY CBFYM-0373 Mouse Human IgG2b Recombinant human MGMT (O6-methylguanine-DNA methyltransferase) purified from E. coli
DMAb-2231-FY CBFYM-0517 Mouse Human IgG3
DMAb-2232-FY CBFYM-0634 Mouse Human IgG1
DMAb-2233-FY CBFYM-0635 Mouse Human IgG1
DMAb-2234-FY CBFYM-0636 Mouse Human IgG2b
DMAb-2235-FY CBFYM-0637 Mouse Human IgG3, k
DMAb-2236-FY CBFYM-2182 Mouse Human IgG1, k
DMAb-2237-FY CBFYM-2183 Mouse Human IgG1 Recombinant human MGMT (O6-methylguanine-DNA methyltransferase) expressed in E. coli
DMAb-2238-FY CBFYM-2184 Mouse Human IgG3, k Partial recombinant corresponding to aa1-100 from human MGMT (AAH00824) with GST tag. MW of the GST tag alone is 26kD.
DMAb-2239-FY CBFYM-2185 Mouse Human IgG1 Full length human recombinant protein of human MGMT (NP_002403) produced in E.coli
DMAb-2240-FY CBFYM-2186 Rat Mouse IgG2a E. coli-derived recombinant mouse MGMT, Met1-Asn211

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-MGMT DNA-encoded mAb (DMAb), pVAX1 (DMAb-2230-FY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.